A randomised, placebo controlled, double blind trial of asenapine in the prevention of relapse after long term treatment of schizophrenia

Update Il y a 4 ans
Reference: EUCTR2004-003340-22

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine the efficacy of asenapine compared to placebo with respect to the time to an impending relapse in schizophrenia subjects who received treatment with asenapine for 26 weeks.


Inclusion criteria

  • Schizophrenia

Links